REIMAGINE 2 Study App 12+
ERT,INC
-
- Free
Screenshots
Description
This app is intended to collect important study-related information from individuals participating in the REIMAGINE 2 clinical study
The REIMAGINE 2 NN9388-4896 Study App will collect information such as doses taken, low blood sugar episodes, participant reported outcomes and more for the clinical study.
Sites participating in the clinical trial are required to create accounts for each participant in the study app before participants can log into the App
What’s New
Version 2.14.0 (75)
Translation updates. Updates condition for visit 2 forms
App Privacy
The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Health & Fitness
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Provider
- ERT, INC has not identified itself as a trader for this app. If you are a consumer in the European Economic Area, consumer rights do not apply to agreements between you and the provider.
- Size
- 88.6 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 12.0 or later.
- iPad
- Requires iPadOS 12.0 or later.
- iPod touch
- Requires iOS 12.0 or later.
- Languages
-
English
- Age Rating
- 12+ Infrequent/Mild Medical/Treatment Information
- Copyright
- © Novo Nordisk, Clario, Medical Outcomes Trust, Quality Metric Inc., Health Psychology Research Ltd., TransCelerate Biopharma Ltd., National Institute of Mental Health (NIMH), Dr. Michelle Dalton
- Price
- Free